AMANDA RINGWOOD: Open Payments
NPI 1053070078 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 12 payments from 5 companies in 2025. Trend: 2023 $582 · 2024 $177 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Madrigal Pharmaceuticals | 2 | $59 |
| ABBVIE INC. | 3 | $47 |
| GENZYME CORPORATION | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $32 |
Products named: REZDIFFRA, DUPIXENT, ENTYVIO, TREMFYA, LINZESS, EOHILIA, SKYRIZI.
Industry payments across IN — which companies pay providers there.
